Immuneering Corp
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: IMRX
Immuneering Corp is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its shares trade on Nasdaq under the ticker IMRX. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2025.
Immuneering at a glance
What does Immuneering do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $25 million sold (2025).
Frequently asked questions about Immuneering
Where is Immuneering headquartered?
Immuneering Corp is headquartered in Cambridge, Massachusetts, United States.
What does Immuneering do?
Immuneering Corp is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Immuneering a public company?
Yes. Immuneering Corp trades on Nasdaq under the ticker IMRX.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.